The Integration of a Mobile App Platform With Biomarkers in Kidney Transplantation

  • End date
    Oct 31, 2023
  • participants needed
  • sponsor
    Duke University
Updated on 27 January 2021


The purpose of this study is to examine the feasibility and acceptability of a mobile app to improve self-management skills and medication adherence in kidney transplantation, to assess the clinical benefit of mobile app in combination with tailored coaching using text messaging to enhance patient activation, self-management and medication adherence and to determine whether immunological biomarkers such as cell-free DNA and donor specific antibodies are associated with self-management and medication adherence.

Condition Noncompliance with medication regimen
Treatment Smartphone APP, Tailored education
Clinical Study IdentifierNCT04382248
SponsorDuke University
Last Modified on27 January 2021


Yes No Not Sure

Inclusion Criteria

Is your age between 12 yrs and 40 yrs?
Gender: Male or Female
Do you have Noncompliance with medication regimen?
Do you have any of these conditions: Do you have Noncompliance with medication regimen??
) age 12-40 kidney transplant recipients with stable kidney function at least one month from the time of transplantation
) have and use a smartphone
) patients without pre-formed antibodies

Exclusion Criteria

) Patients <12 or >40
) patient with pre-existing antibodies
) patients with rejection at the time of enrollment
) patients without a smartphone
) patients with developmental delay or psychological impairment and unable to use an app
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Phone Email

Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note